IIFL Home Finance gears up for IPO, looks to raise Rs5,000 crore through direct assignment
The Asset Under Management (AUM) stood at Rs23,617 crore as of March 31, 2022....
India Infoline News Service | Mumbai 11:36 IST | June 14, 2022
Windlas Biotech bags EU-GMP certificate; stock trades flat
The company had undergone an inspection between April 11 to April 13, 2022....
India Infoline News Service | Mumbai 10:24 IST | May 25, 2022
Board of Windlas Biotech recommends Final Dividend
Board of Windlas Biotech recommends Final Dividend of Rs.3.50 per share
capital market | Mumbai 11:57 IST | May 13, 2022
Windlas Biotech consolidated net profit rises 150.68% in the March 2022 quarter
Windlas Biotech consolidated net profit rises 150.68% in the March 2022 quarter sales rise 14.34% to Rs 122.13 crore
capital market | Mumbai 17:13 IST | May 12, 2022
Windlas Biotech Limited - Monitoring Agency Report
Windlas Biotech Limited - Monitoring Agency Report windlas Biotech Limited - Monitoring Agency Report
capital market | Mumbai 00:00 IST | May 12, 2022
Windlas Biotech soars on zero observations at Dehradun unit; bags GMP certificate from SAHPRA
Windlas Biotech soars on zero observations at Dehradun unit; bags GMP certificate from SAHPRA windlas Biotech surged 12.34% to Rs 265.40 after the company concluded its European Union GMP Inspection carried out by National Institute of Pharmacy and Nutrition, Hungary for the Plant-IV situated at Dehradun with zero critical observations.
capital market | Mumbai 12:49 IST | April 18, 2022
Windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates
capital market | Mumbai 00:00 IST | February 17, 2022
Windlas Biotech consolidated net profit declines 32.33% in the December 2021 quarter
Windlas Biotech consolidated net profit declines 32.33% in the December 2021 quarter sales rise 0.33% to Rs 117.59 crore
capital market | Mumbai 15:03 IST | February 02, 2022
Windlas Biotech stock skyrockets 5% on concluding SAHPRA audit and ahead of Q3 earnings
The company had undergone the inspection audit from 20th to 29th September 2021....
India Infoline News Service | Mumbai 12:20 IST | February 02, 2022
Windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates
capital market | Mumbai 00:00 IST | February 02, 2022
Windlas Biotech to declare Quarterly Result
Windlas Biotech to declare Quarterly Result on 2 February 2022
capital market | Mumbai 12:58 IST | January 27, 2022
Windlas Biotech appoints Shailendra Rastogi as Chief Business Officer
Rastogi will be responsible for handling CDMO, Export, API & CRAMS business development for the company....
India Infoline News Service | Mumbai 12:16 IST | December 22, 2021
Windlas Biotech Limited - Press Release
Windlas Biotech Limited - Press Release windlas Biotech Limited - Press Release
capital market | Mumbai 00:00 IST | December 22, 2021
Windlas Biotech appoints Chief Business Officer
Windlas Biotech appoints Chief Business Officer windlas Biotech appoints Chief Business Officer
capital market | Mumbai 18:38 IST | December 21, 2021
Windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates
capital market | Mumbai 00:00 IST | November 18, 2021
Windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates
capital market | Mumbai 00:00 IST | November 09, 2021
Windlas Biotech Limited - Monitoring Agency Report
Windlas Biotech Limited - Monitoring Agency Report windlas Biotech Limited - Monitoring Agency Report
capital market | Mumbai 00:00 IST | November 02, 2021
Windlas Biotech consolidated net profit declines 12.08% in the September 2021 quarter
Windlas Biotech consolidated net profit declines 12.08% in the September 2021 quarter sales rise 13.75% to Rs 115.25 crore
capital market | Mumbai 16:51 IST | November 01, 2021
Windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates windlas Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates
capital market | Mumbai 00:00 IST | October 27, 2021